I think they will show the appearance that HHS is very important...

I think they will show the appearance that HHS is very important to them. Of course if it was they would have extracted value out of it for 40-60 million and used that cash to strengthen its core business. Bottom line there are no healthcare experts in HHS, they use another company's technology, and the nurse call business is hemorrhaging. Poor implementations, delayed contract signings and competition from others will pull it down further in 2017. I have even heard of recent cancelations of implementations because of poor execution.

Utterly foolish why they did not tie up others longer and tighter. They paid individuals with those companies 100's of thousands for business that only went away after deal closing.

New CEO has no experience in healthcare, is not CEO material imho and there are bloated with staff. At best with long sales cycles it would be back half of 2018 before you could improve.

I would have thought shareholders would have sued JHL and board by now as well as Questek folks. the money she burns and value killed is undeniable, yet she stays.